Description
CONTRACTOR TO PROVIDE CHEMISTRY AND IMMUNOASSAY EQUIPMENT AND REAGENTS UNDER A COST-PER-TEST BPA TO VA MEDICAL FACILITIES IN VISN-23. AMEND #14 EXTENDED BPA TO JUNE 30, 2011
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-12-23+$13,138= $13,138
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-12-23 | +$13,138 | $13,138 | CONTRACTOR TO PROVIDE CHEMISTRY AND IMMUNOASSAY EQUIPMENT AND REAGENTS UNDER A COST-PER-TEST BPA TO VA MEDICAL… |
Related awards · 9
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under 6630 from 568-VA BLACK HILLS HEALTH CARE SYSTEM (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| V568C10365 | NIPPON SANSO MATHESON, INC. | 568-VA BLACK HILLS HEALTH CARE SYSTEM | $36,000 | FY2011 |
| VA568P16962 | CEPHEID | 568-VA BLACK HILLS HEALTH CARE SYSTEM | $5,087 | FY2011 |
| V568P0K130 | FISHER SCIENTIFIC COMPANY L.L.C. | 568-VA BLACK HILLS HEALTH CARE SYSTEM | $9,354 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26312F0519_3600_VBPA6180205_3600 · retrieved 2026-09-26.